Rare FDA Move Shows Stance On Remote Monitoring Devices
On May 25, the U.S. Food and Drug Administration issued a warning letter to iRhythm Technologies Inc., citing a deluge of violations related to the company's heart-monitoring device — the Zio...To view the full article, register now.
Already a subscriber? Click here to view full article